Sexual dimorphism in angiotensin II-induced hypertension and vascular alterations

Canadian Journal of Physiology and Pharmacology

Volumn 83, Issue 5, 2005, Pages 413-422

  Tatchum Talom, R ^a,b   Eyster, K M ^a   Martin, D S ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b St George University   (Grenada)

Author keywords

Angiotensin II hypertension; Blood pressure; Gender; Vascular endothelium

Indexed keywords

ANGIOTENSIN; GLYCOPROTEIN GP 67; GLYCOPROTEIN P; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE TIME EFFECT RELATION; FEMALE; HYPERTENSION; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; VASCULAR DISEASE;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; BODY WEIGHT; DRINKING; EATING; FEMALE; HYPERTENSION; MALE; NOREPINEPHRINE; PERFUSION; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEX CHARACTERISTICS; SPLANCHNIC CIRCULATION; VASOCONSTRICTION;

EID: 22344452090     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-012     Document Type: Article

References (51)

1. Arnal, J.F., Clamens, S., Pechet, C., Negre-Salvayre, A., Allera, C., Girolami, J.P. et al. 1996. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc. Natl. Acad. Sci. U.S.A. 93: 4108-4113.
2. Barbacanne, M.A., Rami, J., Michel, J.B., Souchard, J.P., Philippe, M., Besombes, J.P. et al. 1999. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: possible role of decreased endothelium-derived superoxide anion production. Cardiovasc. Res. 41: 672-681.
3. Basso, N., and Terragno, N.A. 2001. History about the discovery of the renin-angiotensin system. Hypertension, 38: 1246-1249.
4. Berry, C., Touyz, R., Dominiczak, A.F., Webb, R.C., and Johns, D.G. 2001. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am. J. Physiol. 281: H2337-H2365.
5. Brosnihan, K.B., Li, P., and Ferrario, C.M. 1996. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension, 27: 523-528.
6. Brosnihan, K.B., Li, P., Ganten, D., and Ferrario, C.M. 1997. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor- vasodilator balance of RAS. Am J Physiol. 273: R1908-R1915.
7. Brown, A.J., Casals-Stenzel, J., Gofford, S, Lever, A.F., and Morton, J.J. 1997. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am. J. Physiol. 241: H381-H388.
8. Crofton, J.T., and Share, L. 1997. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension, 29: 494-499.
9. Dantas, A.P., Tostes, R.C., Fortes, Z.B., Costa, S.G., Nigro, D., and Carvalho, M.H. 2002. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension, 39: 405-411.
10. Diep, Q.N., El Mabrouk, M., Cohn, J.S., Endemann, D., Amiri, F., Virdis, A. et al. 2002. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation, 105: 2296-2302.
11. Dowell, F.J., Henrion, D., Benessiano, J., Poitevin, P., and Levy, B.I. 1996. Chronic infusion of low-dose angiotensin II potentiates the adrenergic response in vivo. J. Hypertens. 14: 177-182.
12. Dzau, V.J., Burt, D.W., and Pratt, R.E. 1988. Molecular biology of the renin-angiotensin system. Am. J. Physiol. 255: F563-F573.
13. Eatman, D., Wang, M., Socii, R.R., Thierry-Palmer, M., Emmett, N., and Bayorh, M.A. 2001. Gender differences in the attenuation of salt-induced hypertension by angiotensin (1-7). Peptides, 22: 927-933.
14. Ferrario, C.M. 1998. Angiotension-(1-7) and antihypertensive mechanisms. J. Nephrol. 11: 278-283.
15. Ferrario, C.M., Chappell, M.C., Tallant, E.A., Brosnihan, K.B., and Diz, D.I. 1997. Counterregulatory actions of angiotensin-(1-7). Hypertension, 30: 535-541.
16. Galipeau, D., Verma, S., and McNeill, J.H. 2002a. Female rats are protected against fructose-induced changes in metabolism and blood pressure. Am. J. Physiol. 283: H2478-H2484.
17. Galipeau, D., Yao, L., and McNeill, J.H. 2002b. Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex. Am. J. Physiol. 283: H562-H567.
18. Gandhi, S.K., Gainer, J., King, D., and Brown, N.J. 1998. Gender affects renal vasoconstrictor response to Ang I and Ang II. Hypertension, 31: 90-96.
19. Gragasin, F.S., Xu, Y., Arenas, I.A., Kainth, N., and Davidge, S.T. 2003. Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23: 38-44.
20. Haas, J.A., Krier, J.D., Bolterman, R.J., Juncos, L.A., and Romero, J.C. 1999. Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension, 34: 983-986.
21. Henrion, D., Laher, I., Laporte, R., and Bevan, J.A. 1992. Angiotensin II amplifies arterial contractile responses to norepinephrine without increasing Ca++ influx: role of protein kinase C. J. Pharmacol. Exp. Ther. 261: 835-840.
22. Hinojosa-Laborde, C., Lange, D.L., and Haywood, J.R. 2000. Role of female sex hormones in the development and reversal of Dahl hypertension. Hypertension, 35: 484-489.
23. Iyer, S.N., Katovich, M.J., Raizada, M.K. 1996. Changes in angiotensin ATI receptor density during hypertension in fructose-fed rats. Adv. Exp. Med. Biol. 396: 49-58.
24. Kerr, S., Brosnan, M.J., McIntyre, M., Reid, J.L., Dominiczak, A.F., and Hamilton, C.A. 1999. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension, 33: 1353-1358.
25. Kim, S., and Iwao, H. 2000. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 52: 11-34.
26. Lange, D.L., Haywood, J.R., and Hinojosa-Laborde, C. 1998. Role of the adrenal medullae in male and female DOCA-salt hypertensive rats. Hypertension, 31: 403-408.
27. Laursen, J.B., Rajagopalan, S., Galis, Z., Tarpey, M., Freeman, B.A., and Harrison, D.G. 1997. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation, 95: 588-593.
28. McIntyre, M., Bohr, D.F., and Dominiczak, A.F. 1999. Endothelial function in hypertension: the role of superoxide anion. Hypertension, 34: 539-545.
29. Mendelsohn, M.E., and Karas, R.H. 1999. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340: 1801-1811.
30. Mihm, M.J., Wattanapitayakul, S.K., Piao, S.F., Hoyt, D.G., and Bauer, J.A. 2003. Effects of angiotensin II on vascular endothelial cells: formation of receptor-mediated reactive nitrogen species. Biochem. Pharmacol. 65: 1189-1197.
31. Neves, L.A., Averill, D.B., Ferrario, C.M., Chappell, M.C., Aschner, J.L., Alkup, M.O. et al. 2003. Characterization of angiotensin-(1-7) receptor subtype in mesenteric arteries. Peptides, 24: 455-462.
32. Navarro-Cid, J., Maeso, R., Perez-Vizcaino, F., Cachofeiro, V., Ruilope, L.M., Tamargo, J. et al. 1995. Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat. Hypertension, 26: 1074-1078.
33. Nickenig, G., Strehlow, K., Wassmann, S., Baumer, A.T., Albory, K., Sauer, H. et al. 2000. Differential effects of estrogen and progesterone on AT(1) receptor gene expression in vascular smooth muscle cells. Circulation, 102: 1828-1833.
34. Ortiz, M.C., Manriquez, M.C., Romero, J.C., and Juncos, L.A. 2001. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension, 38: 655-659.
35. Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B.A., Griendling, K.K. et al. 1996. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Investig. 97: 1916-1923.
36. Reckelhoff, J.F. 2001. Gender differences in the regulation of blood pressure. Hypertension, 37: 1199-1208.
37. Reckelhoff, J.F., and Romero, J.C. 2003. Role of oxidative stress in angiotensin-induced hypertension. Am. J. Physiol. 284: R893-R912.
38. Reckelhoff, J.F., Zhang, H., and Granger, J.P. 1997. Decline in renal hemodynamic function in aging SHR: role of androgens. Hypertension, 30: 677-681.
39. Reckelhoff, J.F., Zhang, H., and Srivastava, K. 2000. Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension, 35: 480-483.
40. Romero, J.C., and Reckelhoff, J.F. 1999. State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension, 34: 943-949.
41. Rosendorff, C. 1996. The renin-angiotensin system and vascular hypertrophy. J. Am. Coll. Cardiol. 28: 803-812.
42. Talom, R.T., Judd, S.A., McIntosh, D.D., and McNeill, J.R. 1999. High flaxseed (linseed) diet restores endothelial function in the mesenteric arterial bed of spontaneously hypertensive rats. Life Sci. 64: 1415-1425.
43. Touyz, R.M., and Schiffrin, E.L. 2000. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 52: 639-672.
44. Unger, T. 2002. The role of the renin-angiotensin system in the development of cardiovascular disease. Am. J. Cardiol. 89: 3A-9A.
45. Virdis, A., Neves, M.F., Amiri, F., Viel, E., Touyz, R.M., and Schiffrin, E.L. 2002. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension, 40: 504-510.
46. Wagner, A.H., Schroeter, M.R., and Hecker, M. 2001. 17β-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J. 15: 2121-2130.
47. Wattanapitayakul, S.K., Weinstein, D.M., Holycross, B.J., and Bauer, J.A. 2000. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J. 14: 271-278.
48. Wu, W., Zhang, Y., Ballew, J.R., Fink, G., and Wang, D.H. 2000. Development of hypertension induced by subpressor infusion of angiotensin II: role of sensory nerves. Hypertension, 36: 549-552.
49. Zhang, H., Schmeisser, A., Garlichs, C.D., Plotze, K., Damme, U., Mugge, A. et al. 1999. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc. Res. 44: 215-222.
50. Zhang, C., Heun, T.W., Wang, W., and Kuo, L. 2003. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ. Res. 92: 322-329.
51. Zicha, J., and Kunes, J. 1999. Ontogenetic aspects of hypertension development: analysis in the rat. Physiol. Rev. 79: 1227-1282.